Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, Korea, talks on key lectures presented at the European Society for Medical Oncology (ESMO) Breast Cancer meeting 2022, including on the controversial issue in breast cancer oncology of whether we can decrease chemotherapy in premenopausal woman with node positive breast cancer of 1-3 lymph nodes. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.